{"organizations": [], "uuid": "cbf4d4432d3b1674b9e1aa74714c230d053e0502", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-immunocellular-therapeutics-announ/brief-immunocellular-therapeutics-announces-achievement-of-next-key-milestone-in-stem-to-t-cell-research-immuno-oncology-program-idUSFWN1RP07F", "country": "US", "domain_rank": 408, "title": "BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone In Stem-To-T-Cell Research Immuno Oncology Program", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T13:10:00.000+03:00", "replies_count": 0, "uuid": "cbf4d4432d3b1674b9e1aa74714c230d053e0502"}, "author": "", "url": "https://www.reuters.com/article/brief-immunocellular-therapeutics-announ/brief-immunocellular-therapeutics-announces-achievement-of-next-key-milestone-in-stem-to-t-cell-research-immuno-oncology-program-idUSFWN1RP07F", "ord_in_thread": 0, "title": "BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone In Stem-To-T-Cell Research Immuno Oncology Program", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "stem-to-t-cell research immuno", "sentiment": "negative"}, {"name": "immunocellular therapeutics ltd", "sentiment": "none"}, {"name": "stem-to-t-cell research immuno oncology program reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12, 2018 / 10:10 AM / in 8 minutes BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone In Stem-To-T-Cell Research Immuno Oncology Program Reuters Staff \nApril 12 (Reuters) - ImmunoCellular Therapeutics Ltd : \n* IMMUNOCELLULAR THERAPEUTICS ANNOUNCES ACHIEVEMENT OF NEXT KEY MILESTONE IN STEM-TO-T-CELL RESEARCH IMMUNO-ONCOLOGY PROGRAM \n* BEEN ABLE TO VERIFY SUCCESSFUL TRANSFER OF SELECTED T CELL RECEPTOR GENETIC MATERIAL INTO HUMAN HEMATOPOIETIC STEM CELLS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-12T13:10:00.000+03:00", "crawled": "2018-04-12T13:25:09.017+03:00", "highlightTitle": ""}